Pfizer · NSE: PFIZER · BSE: 500680
Q2 FY20 results · Jul–Sep 2019
Pfizer reported revenue from operations of ₹567.06 crore (up 9.1% from Q2 FY19) and net profit of ₹154.25 crore (up 61.0% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a standalone basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 567.06 | 519.74 | +9.1% | 544.40 | +4.2% |
| Other income | 44.75 | 37.06 | +20.8% | 35.83 | +24.9% |
| Total income | 611.81 | 556.80 | +9.9% | 580.23 | +5.4% |
| Profit before tax | 181.18 | 148.88 | +21.7% | 174.91 | +3.6% |
| Net profit for the period | 154.25 | 95.80 | +61.0% | 112.81 | +36.7% |
| EPS, basic (₹) | 33.72 | 20.94 | +61.0% | 24.66 | +36.7% |
| Net margin (%) | 27.2 | 18.4 | 20.7 |
Standalone
- Filed with BSE
- 26 Oct 2019, 18:57 IST
- Board meeting
- 26 Oct 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE